Loading…
Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients
Male Breast Cancer (MBC) is a rare and aggressive disease that is associated with genetic factors. Mutations in BRCA1 and BRCA2 account for 10% of all MBC cases suggesting that other genetic factors are involved. The aim of the present study is to screen whole BRCA1 and BRCA2 exons using the Ampl...
Saved in:
Published in: | Molecular biology reports 2020-09, Vol.47 (9), p.6507-6516 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Male Breast Cancer (MBC) is a rare and aggressive disease that is associated with genetic factors. Mutations in
BRCA1
and
BRCA2
account for 10% of all MBC cases suggesting that other genetic factors are involved. The aim of the present study is to screen whole
BRCA1
and
BRCA2
exons using the Ampliseq BRCA panel in Tunisian MBC patients with family history. Furthermore, we performed exome sequencing using the TruSight One sequencing panel on an early onset
BRCA
negative patient. We showed that among the 6 MBC patients, only one (MBC-F1) harbored a novel frameshift mutation in exon 2 of the
BRCA2
gene (c.17-20delAAGA, p.Lys6Xfs) resulting in a short BRCA2 protein of only 6 amino-acids. We selected 9 rare variants after applying several filter steps on the exome sequencing data. Among these variants, and based on their role in breast carcinogenesis, we retained 6 candidate genes (
MSH5, DCC, ERBB3, NOTCH3, DIAPH1,
and
DNAH11
). Further studies are needed to confirm the association of the selected genes with family MBC. |
---|---|
ISSN: | 0301-4851 1573-4978 |
DOI: | 10.1007/s11033-020-05703-0 |